Adenovirus-mediated apo(a)-antisense-RNA expression efficiency inhibits apo(a) synthesis in vitro and in vivo

Gene Therapy

Volumn 8, Issue 6, 2001, Pages 425-430

  Frank, S ^a   Gauster, M ^a   Strauss, J ^a   Hrzenjak, A ^a   Kostner, G M ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Adenovirus; Antisense RNA; Atherosclerosis; Transgenic apo(a) mice

Indexed keywords

APOLIPOPROTEIN A; COMPLEMENTARY RNA; LIPOPROTEIN A; MESSENGER RNA; PLASMA PROTEIN;

5' UNTRANSLATED REGION; ADENOVIRUS; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATHEROGENESIS; BIOSYNTHESIS; BLOOD LEVEL; CAUCASIAN; CONTROLLED STUDY; DRUG SAFETY; EXPERIMENTAL ANIMAL; GENE TECHNOLOGY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT GENE; KRINGLE DOMAIN; LIPOPROTEIN SYNTHESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; REFERENCE VALUE; VIRUS INFECTION;

ADENOVIRIDAE; ANIMALS; ARTERIOSCLEROSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; GENE THERAPY; GENETIC VECTORS; IMMUNOASSAY; LIPOPROTEIN(A); LIVER NEOPLASMS; MICE; MICE, TRANSGENIC; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, ANTISENSE; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES;

EID: 0035069957     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301434     Document Type: Article

References (34)

1. Lipoprotein(a)
2. Lipoprotein Lp(a) and the risk for myocardial infarction
3. Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis
4. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate
5. Lipoprotein(a)
6. cDNA sequence of human apo-lipoprotein(a) is homologous to plasminogen
7. Structural properties of apo(a): A major apoprotein of human lipoprotein(a)
8. Molecular definition of the extreme size polymorphism in apolipoprotein(a)
9. The apoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms
10. Lipoprotein(a) as a risk factor for ischemic heart disease: Metaanalysis of prospective studies
11. Atherogenesis in transgenic mice expressing human apolipoprotein(a)
12. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein(a)
13. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice
14. Feedback mechanism of focal vascular lesion formation in transgenic apolipoprotein(a) mice
15. HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels
16. Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid
17. The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover
18. Reduction of lecithin cholesterol acyltransferase, apolipoprotein D and the LP(a) lipoprotein with the anabolic sterol stanazolol
19. Aspirin reduces apolipoprotein(a) (apo((a)) production in human hepatocytes by suppression of apo(a) gene transcription
20. Escherichia coli ribonuclease III cleavage sites
21. RNase III cleaves eukaryotic preribosomal RNA at a U3 snoRNP-dependent site
22. Purification and characterization of the Pac1 ribonuclease of Schizosaccharomyces pombe
23. Adenovirus-mediated expression of human coagulation factor IX in the rhesus macaque is associated with dose-limiting toxicity
24. Virus treatment questioned after gene therapy death
25. High-capacity adenoviral vectors for gene transfer and somatic gene therapy
26. High doses of a helper-dependent adenoviral vector yield supraphysiological levels of α1-antitrypsin with negligible toxicity
27. Changes in plasma lipoprotein cholesterol levels by antisense oligodeoxynucleotides against cholesteryl ester transfer protein in cholesterol-fed rabbits
28. The role of apo(a) kringle IVs in the assembly of lipoprotein(a)
29. Effect of tranexamic acid and ∂-aminovaleric acid on lipoprotein(a) metabolism in transgenic mice
30. Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor
31. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5
32. A new technique for the assay of infectivity of human adenovirus IV DNA
33. Adenovirus-mediated gene transfer of a rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production
34. Structural requirements of apo(a) for the lipoprotein(a) assembly